• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在短期监禁人群中治疗丙型肝炎的可行性。

Feasibility of Treating Hepatitis C in a Transient Jail Population.

作者信息

MacDonald Ross, Akiyama Matthew J, Kopolow Aimee, Rosner Zachary, McGahee Wendy, Joseph Rodrigue, Jaffer Mohamed, Venters Homer

机构信息

Correctional Health Services, New York City Health + Hospitals, Bronx; and.

Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.

出版信息

Open Forum Infect Dis. 2017 Jul 7;4(3):ofx142. doi: 10.1093/ofid/ofx142. eCollection 2017 Summer.

DOI:10.1093/ofid/ofx142
PMID:28852680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5569928/
Abstract

Jails represent a critical component of the public health response to HCV elimination. We report on outcomes of 104 patients receiving HCV treatment from January 1, 2014 to June 30, 2016 in a large urban jail setting. Our data demonstrate that treatment in jails is feasible, but many barriers remain.

摘要

监狱是公共卫生应对丙型肝炎病毒消除工作的关键组成部分。我们报告了2014年1月1日至2016年6月30日期间在一个大型城市监狱环境中接受丙型肝炎病毒治疗的104名患者的治疗结果。我们的数据表明，在监狱中进行治疗是可行的，但仍存在许多障碍。

相似文献

1
Feasibility of Treating Hepatitis C in a Transient Jail Population.在短期监禁人群中治疗丙型肝炎的可行性。
Open Forum Infect Dis. 2017 Jul 7;4(3):ofx142. doi: 10.1093/ofid/ofx142. eCollection 2017 Summer.
2
The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014-2017.2014 - 2017年直接抗病毒治疗时代纽约市监狱系统中的丙型肝炎病毒治疗流程
EClinicalMedicine. 2020 Oct 5;27:100567. doi: 10.1016/j.eclinm.2020.100567. eCollection 2020 Oct.
3
Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014.2012 - 2014年北卡罗来纳州和南卡罗来纳州监狱中的丙型肝炎病毒检测及与医疗服务的联系
Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):98-104. doi: 10.1177/00333549161310S215.
4
Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.高危农村妇女中的丙型肝炎抗体反应性：刑事司法系统中的服务与治疗机会
Int J Prison Health. 2018 Jun 11;14(2):89-100. doi: 10.1108/IJPH-03-2017-0012.
5
Rapid HIV Screening in an Urban Jail: How Testing at Exit With Linkage to Community Care Can Address Perceived Barriers.城市监狱中的快速艾滋病毒筛查：通过出狱时检测并与社区护理相联系如何克服认知障碍。
J Prim Prev. 2015 Dec;36(6):427-32. doi: 10.1007/s10935-015-0408-1.
6
The contribution of a urine-based jail screening program to citywide male Chlamydia and gonorrhea case rates in New York City.基于尿液的监狱筛查项目对纽约市全市男性衣原体和淋病发病率的贡献。
Sex Transm Dis. 2009 Feb;36(2 Suppl):S58-61. doi: 10.1097/OLQ.0b013e31815615bb.
7
Hepatitis C Screening of the "Birth Cohort" (Born 1945-1965) and Younger Inmates of New York City Jails.纽约市监狱中“出生队列”（出生于1945年至1965年）及年轻囚犯的丙型肝炎筛查
Am J Public Health. 2016 Jul;106(7):1276-7. doi: 10.2105/AJPH.2016.303163. Epub 2016 May 19.
8
The critical link between health care and jails.医疗保健与监狱之间的关键联系。
Health Aff (Millwood). 2014 Mar;33(3):443-7. doi: 10.1377/hlthaff.2013.1350.
9
Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.解决美国监禁人群中的丙型肝炎问题：实现全国消除的策略。
Curr HIV/AIDS Rep. 2020 Feb;17(1):18-25. doi: 10.1007/s11904-019-00476-z.
10
The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care.直接作用抗病毒药物在持续存在治疗障碍的 HIV 感染患者中的丙型肝炎病毒持续应答中的影响。
Open Forum Infect Dis. 2015 Nov 12;2(4):ofv168. doi: 10.1093/ofid/ofv168. eCollection 2015 Dec.

引用本文的文献

1
Hepatitis C Testing Protocols Across Massachusetts Jails, 2022-2023: An Opportunity for Intervention.2022 - 2023年马萨诸塞州各监狱的丙型肝炎检测方案：干预的契机
Public Health Rep. 2025 Jun 16:333549251325067. doi: 10.1177/00333549251325067.
2
Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States.美国州立监狱人群中丙型肝炎血清流行率和病毒血症的估计。
J Infect Dis. 2023 Sep 13;228(Suppl 3):S160-S167. doi: 10.1093/infdis/jiad227.
3
US Hepatitis C Elimination Plan.美国丙型肝炎消除计划。
JAMA. 2023 Sep 5;330(9):877-878. doi: 10.1001/jama.2023.11757.
4
Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study.美国新泽西州监禁期间及之后的丙型肝炎治疗可及性：一项定性研究
Life (Basel). 2023 Apr 17;13(4):1033. doi: 10.3390/life13041033.
5
Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be?加拿大惩教机构中的丙型肝炎病毒（HCV）护理：我们现状如何，又需要达到何种状态？
Can Liver J. 2019 Dec 10;2(4):171-183. doi: 10.3138/canlivj.2019-0007. eCollection 2019 Fall.
6
The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.直接作用抗病毒药物治疗方案和远程医疗对以色列监狱丙型肝炎病毒感染者治疗的影响。
Sci Prog. 2022 Apr-Jun;105(2):368504221105173. doi: 10.1177/00368504221105173.
7
Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.大城市监狱中的丙型肝炎流行病学：人口统计学的变化。
Public Health Rep. 2023 Mar-Apr;138(2):248-258. doi: 10.1177/00333549221076546. Epub 2022 Mar 3.
8
Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.纽约市丙型肝炎病毒感染者首次 RNA 阴性检测结果与无家可归或在惩教或药物使用治疗机构进行检测之间的关联。
Public Health Rep. 2022 Nov-Dec;137(6):1126-1135. doi: 10.1177/00333549211049263. Epub 2021 Oct 25.
9
Management of Hepatitis C in Delaware Prisons: : Approaching Microenvironmental Eradication.特拉华州监狱丙型肝炎的管理：迈向微环境根除
Dela J Public Health. 2019 May 28;5(2):20-27. doi: 10.32481/djph.2019.05.006. eCollection 2019 May.
10
"I'm not gonna be able to do anything about it, then what's the point?": A broad group of stakeholders identify barriers and facilitators to HCV testing in a Massachusetts jail.“如果我对此无能为力，那又有什么意义呢？”：马萨诸塞州监狱内广泛的利益相关者群体确定了丙型肝炎病毒检测的障碍和促进因素。
PLoS One. 2021 May 26;16(5):e0250901. doi: 10.1371/journal.pone.0250901. eCollection 2021.

本文引用的文献

1
New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners.新型丙型肝炎药物价格高昂，许多州立监狱的囚犯无法获得。
Health Aff (Millwood). 2016 Oct 1;35(10):1893-1901. doi: 10.1377/hlthaff.2016.0296.
2
Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.美国监狱中通过筛查和治疗预防丙型肝炎
Ann Intern Med. 2016 Jan 19;164(2):84-92. doi: 10.7326/M15-0617. Epub 2015 Nov 24.
3
Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis.基于索非布韦的治疗方案用于美国监狱人群慢性1型丙型肝炎病毒感染的成本效益分析
Ann Intern Med. 2014 Oct 21;161(8):546-53. doi: 10.7326/M14-0602.
4
Responding to hepatitis C through the criminal justice system.通过刑事司法系统应对丙型肝炎。
N Engl J Med. 2014 May 15;370(20):1871-4. doi: 10.1056/NEJMp1311941.
5
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.来迪派韦索磷布韦片治疗既往治疗的 HCV 基因 1 型感染。
N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.